Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors. 1992

R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
Cerebrovascular Research Center, University of Pennsylvania, Philadelphia 19104-6063.

Two series of N-substituted spiperone analogues were prepared and evaluated in vitro to measure their affinities for dopamine D2 and serotonin 5-HT2 receptors. Substitution of the amide nitrogen with an alkyl group of five carbon units or less resulted in analogues displaying a low selectivity for D2 compared to 5-HT2 receptors. However, a moderate improvement in selectivity for D2 receptors was observed with N-benzylspiperone. Substitution at either the ortho or para position of the benzyl group resulted in a further reduction in affinity for 5-HT2 receptors and improvement in the selectivity ratio. Examination of N-substituted analogues of spiperone may provide insights into the topography of the antagonist binding region of the 5-HT2 receptor. The results also suggest that an 18F-labeled analogue of N-(4-nitrobenzyl)spiperone (4p) may be a suitable tracer for studying D2 receptors with positron emission tomography since this compound displays a high selectivity for D2 receptors relative to that of spiperone and N-methylspiperone.

UI MeSH Term Description Entries
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
January 1985, Polish journal of pharmacology and pharmacy,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
January 1990, Life sciences,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
November 1984, Life sciences,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
September 1996, Journal of medicinal chemistry,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
May 1993, Progress in neuro-psychopharmacology & biological psychiatry,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
January 1992, Clinical neuropharmacology,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
June 1999, Bioorganic & medicinal chemistry,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
May 1989, Brain research,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
March 1995, Journal of medicinal chemistry,
R H Mach, and J R Jackson, and R R Luedtke, and K J Ivins, and P B Molinoff, and R L Ehrenkaufer
April 1994, Journal of medicinal chemistry,
Copied contents to your clipboard!